Community-Based Intervention for Active Detection and Provision of Single-Dose Rifampicin Post-Exposure Prophylaxis to Household Contacts of Leprosy in Bolivia

Author:

Baptista Mora Abundio1,Ortuño-Gutiérrez Nimer2ORCID,Zurita Paniagua Deisy3,Hurtado Solares Carlos4,Fastenau Anil5ORCID,Kasang Christa5

Affiliation:

1. German Leprosy and Tuberculosis Relief Association (GLRA), Sucre 0000, Bolivia

2. Damien Foundation, 1081 Brussels, Belgium

3. Dermatological Hospital of Jorochito, Santa Cruz 00591, Bolivia

4. Epidemiology, Departmental Health Service, Santa Cruz 00591, Bolivia

5. German Leprosy and Tuberculosis Relief Association (GLRA), 97080 Wurtzbourg, Germany

Abstract

Background: To achieve zero leprosy cases in Santa Cruz, Bolivia, we designed a community-based active detection and provision of single-dose rifampicin post-exposure prophylaxis (SDR-PEP) to household contacts with new leprosy patients. Methods: From July to August 2021, we assessed the current knowledge, attitude, and practices through structured interviews and focus group discussions with community representatives and health staff. This was followed by sensitization sessions, the training of health staff, and the reinforcement of referral mechanisms. Teams, including health staff and community volunteers, visited all new leprosy patients detected in 2021–2023 and household contacts. Results: Among 115 community representatives, knowledge about leprosy etiology was attributed to non-biological factors (74%); fear accounted for 77%, and access to care was perceived as weak (74%), but the outlook was improved by SDR-PEP (80%). Among the 217 health staff interviewed, the programmatic barriers identified were a lack of referral feedback (67%), limited supplies for diagnosis and prevention, and ineffective training (64%). We visited 70 new patients and 258 household contacts. The median age in household contacts was 25 years old; 49% were women, 98% were eligible for SDR-PEP, and all who were eligible accepted it. Those who were non-eligible included one tuberculosis patient and six newly detected leprosy patients (23‰). Conclusions: A community-based intervention was successful in Santa Cruz, Bolivia. Misbeliefs and a lack of knowledge were identified as barriers. Programmatic components should be reinforced for SDR-PEP extension.

Funder

DAHW German Leprosy and Tuberculosis Relief Association, Chuquisaca, Bolivia

Publisher

MDPI AG

Reference20 articles.

1. World Health Organization (2022, January 01). Towards Zero Leprosy. Global Leprosy (Hansen’s Disease) Strategy 2021–2030. Available online: https://www.who.int/publications/i/item/9789290228509.

2. World Health Organization (2019, January 02). Guidelines for the Diagnosis, Treatment and Prevention of Leprosy. Available online: http://apps.who.int/iris/bitstream/handle/10665/274127/9789290226383-eng.pdf?ua=1.

3. World Health Organization (2022, January 01). Leprosy/Hansen Disease: Contact Tracing and Post-Exposure Prophylaxis. Available online: https://apps.who.int/iris/handle/10665/336679.

4. Khoudri, I., Elyoussfi, Z., Mourchid, Y., Youbi, M., Bennani Mechita, N., Abouqal, R., and Maaroufi, A. (2018). Trend Analysis of Leprosy in Morocco between 2000 and 2017: Evidence on the Single Dose Rifampicin Chemoprophylaxis. PLoS Negl. Trop. Dis., 12.

5. Preventing Leprosy with Retrospective Active Case Finding Combined with Single-Dose Rifampicin for Contacts in a Low Endemic Setting: Results of the Leprosy Post-Exposure Prophylaxis Program in Cambodia;Cavaliero;Acta Trop.,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3